ABSTRACT
Objective To explore the expression of HR and Her?2 in breast cancer primary tumor and axillary lymph node metastasis. Methods Four hundred and twenty?eight female patients with unilateral breast cancer combined with axillary lymph node metastasis treated in the Affiliated Suqian Hospital of Xuzhou Medical University from January 2011 to January 2016 were selected in this study. Immunohistochemistry was used to detect the expression of ER,PR,Her?2 and Ki67 in primary tumor and axillary lymph node metastasis. Results The positive rates of ER expression were 75. 9% ( 325/428 ) and 70. 3% ( 301/428 ) respectively in primary tumor and axillary lymph node metastasis. The positive rates of PR expression were 61. 4% ( 263/428) and 56. 1% ( 240/428 ) respectively in primary tumor and axillary lymph node metastasis. The rates of Her?2 overexpression were 20. 1% ( 86/428) in primary tumor and the positive rate of Her?2 in axillary lymph node metastasis was 22. 7%( 97/428 ) . The positive rates of Ki67 expression were 45. 6%( 195/428 ) and 39. 7%(170/428) respectively in primary tumor and axillary lymph node metastasis. The expression of ER,PR,Her?2 and Ki67 in primary and axillary lymph node metastasis showed no statistical significance ( P>0. 05 ) . The molecular typing of primary tumor and axillary lymph node metastasis were not consistent in 31 patients ( 31/428,7. 24%) ,including 14 cases of primary tumor Luminal A,9 cases of Her?2 overexpression in axillary lymph node metastasis and 5 cases of triple negative breast cancer. Primary tumor Luminal B was detected in 10 cases, while 6 cases of Her?2 overexpression in axillary lymph node metastasis and 4 cases of triple negative breast cancer. Primary tumor Her?2 was overexpressed in 4 cases,while 1 case of Luminal A,3 cases of Luminal B in axillary lymph node metastasis. There were 3 cases of primary tumor triple negative breast cancer,while 2 cases of Luminal B in axillary lymph node metastasis and 1 case of Her?2 overexpression. Conclusion The expressions of ER, PR, Her?2 and Ki67 in primary tumor and axillary lymph node metastasis of some breast cancer were different. Immunohistochemistry for primary tumor and axillary lymph node metastasis of stage II?III breast cancer patients should be routinely carried out. Based on molecular typing of primary tumor and axillary lymph node metastasis,individualized treatment plan can be developed,so that patients will benefit from it.
ABSTRACT
Objective To explore the effects of potassium iodate (KIO3) on the proliferation, cell cycle, and the mRNA/protein levels of cyclin D 1 and Ki67 of SW579 cells, a human thyroid squamous carcinoma cell line . Methods The effects of different doses of KIO3(0,10-6,10-5,10-4,10-3,10-2,10-1 mol/L)on SW579 cell prolifer-ation were assessed by CCK8 method.SW579 cells were then treated with 0 (control), 10-6 or 10-2 mol/L KIO3 for 48 h.The cell cycle was measured by flow cytometry .The mRNA and protein levels of cyclinD 1 and Ki67 were re-spectivelyanalyzedbyreal-timePCRandWesternblot.Results 10-6and10-2mol/LofKIO3respectivelyexhibi-ted the most promoting and suppressive effect on SW579 cell proliferation.G1 phase of cells in 10-6 group short-ened significantly( P<0.05) , and S phase prolonged significantly( P<0.05); while each phase of cells in 10-2 mol/L group changed in the opposite way( P<0.05) .KIO3 at the dose of 10-6 mol/L significantly up-regulated the mRNA levels of cyclin D1 and ki67 in cells( P<0.05) ;whereas, the mRNA and protein levels of cyclin D1 and Ki67 were significantly down-regulated in cells treated with 10-2 mol/L KIO3( P<0.05) .Conclusions Different doses of KIO3 affect the proliferation and cell cycle of SW579 cells probably by regulating the levels of cyclin D1and Ki67 .
ABSTRACT
Resumen: Introducción: El carcinoma oral de células escamosas (COCE) es una neoplasia maligna originada en los queratinocitos del epitelio. Biopsias tempranas, evidencian queratinocitos mitóticos displásicos e infiltrados inflamatorios subepiteliales que progresan a pérdida de la membrana basal. Sin embargo, en el diagnóstico histológico con hematoxilina y eosina (H&E) no se muestra adecuada correlación clínica, aspecto que mejora cuando se utilizan marcadores moleculares como Ki-67 y ciclina D1. El objetivo de este estudio es correlacionar la descripción histológica de casos de COCE con la expresión de Ki-67 y ciclina D1. Material y métodos: Se analizaron 12 pacientes con lesiones sugestivas de cáncer oral; fueron incluidos en el estudio pacientes con diagnóstico de COCE. Se tomaron biopsias únicas, procesamiento histotécnico para cortes en parafina, coloración con H&E y coloración inmunohistoquímica con ciclina D1 y Ki-67. Tres pacientes cumplieron con los criterios de inclusión, llamados C1, C2 y C3. Se clasificó el tipo de COCE según el American Joint Committee on Cancer. Resultados: Histológicamente el caso C1 fue clasificado como COCE tipo II, los casos C2 y C3 tipo I; en la inmunohistoquímica encontramos en C1 Ki-67 positivo y ciclina D1 negativo, para C2, Ki 67 negativo y ciclina D1 positivo y para C3 Ki-67 positivo y ciclina D1 negativo. Conclusiones: La búsqueda de marcadores como Ki67 y ciclina D1 en diagnósticos de COCE preestablecidos, pueden influenciar los resultados histológicos, contribuyendo a un diagnóstico más acertado así como los tratamientos a realizar en el paciente.
Abstract: Introduction: Oral squamous cell carcinoma (OSCC) is a malignant neoplasia originated in the epithelium's keratocytes. Early biopsies reveal dysplastic mitotic keratocytes and sub-epithelial inflammatory infiltrate which progress towards a loss of basal membrane. Nevertheless, hematoxillin and eosin (H&E) histological diagnosis does not show suitable clinical correlation; this aspect improves when molecular markers such as Ki-67 and cyclin D1 are used. The aim of the present study was to correlate histological description of OSCC cases with Ki-676 and cyclin D1 expression. Material and methods: Twelve patients with lesions suggestive of oral cancer were analyzed, patients with OSCC diagnosis were included in the study. Single biopsies were taken, observing histological and technical processing for paraffin cuts, coloration with H&E and immunohistochemical coloration with cyclin D1 and Ki-67. Three patients met inclusion criteria, they were named C1, C2 and C3. OSCC type was classified according to the American Joint Committee on Cancer. Results: Histologically, C1 case was classified as type II OSCC. Cases C2 and C3 were classified as type I OSCC. Immunohistochemical analysis for C1 revealed Ki-67 positive and cyclin D1 negative; C2 exhibited Ki-67 negative and cyclin D1 positive, and C3 showed Ki-67 positive and cyclin D1 negative. Conclusions: Search for markers such as Ki67 and cyclin D1 in pre-established OSCC diagnoses can influence histological results, contributing thus to more accurate diagnosis and treatment for the patients.
ABSTRACT
Objective To investigate the expression of p73 protein in normal skins and lesions of benign and malignant epidermal tumors. Methods By immunohistochemical staining, the expression of p73, p53 and Ki67 was examined in 19 cases of seborrheic keratosis (SK), 16 basal cell carcinoma (BCC), 11 Bowen's disease (BD), 5 squamous cell carcinoma (SCC),as well as in 10 normal skin controls. Results In normal skin, p73 protein was found to distribute in the basal cells of the epidermis, basal cells in the outer root sheath of the hair follicles, and the germinative cells in the sebaceous glands. p73 was expressed strongly in the basal cell-like cells of BCC and SK lesions, and in the atypical cells of BD lesions, but weakly or even negatively in the tumor cells of SCC lesions and the squamous cell-like cells of SK lesions. There was significant difference in the expression of p73 among the SK, BD, BCC and SCC lesions (H=12.71 ,P
ABSTRACT
Objective To explore the expression and significance of transforming growth factor-?(TGF-?),epidermal growth factor receptor (EGFR) and proliferation-related antigen Ki-67 in nephroblastoma. Methods Immunohistochemistry method was used to detect the expression of TGF-?,EGFR and Ki-67 in 8 cases of normal kidney,35 cases of nephroblastoma and 14 cases of the tissues adjacent to nephroblastoma.The differences of their expression were compared among the 3 kinds of tissues and different pathologic characteristics of nephroblastoma. Results The expression rates of TGF-?,EGFR and Ki-67 in nephroblastoma were 51.4%(18/35),62.9%(22/35) and 68.6%(24/35),respectively,which were significantly higher than those in the tissues adjacent to nephroblastoma and the normal kidney;the differences were significant (P0.05);but positive relationship was found between the expression and clinical stages (P